Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 12 of the 16 sources its claims cite were checked for support.

Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes

Open access
Braffett, Barbara H., El ghormli, Laure, Martin, Catherine, White, Neil H., Hirsch, Irl B., Bantle, Anne, Carlson, Anders, Leschek, Ellen, Gubitosi-Klug, Rose, Soliman, Elsayed Z., Vella, Adrian, Perkins, Bruce A., Bebu, Ionut, Pop-Busui, Rodica, for the DCCT/EDIC Research Group · 2025 · Cardiovascular Diabetology

Abstract

BACKGROUND: To describe longitudinal prevalence and risk factors associated with cardiovascular autonomic neuropathy (CAN), defined by heart rate variability (HRV) indices, and evaluate the impact of CAN on cardiovascular disease (CVD), in adults with type 1 diabetes (T1D) from the Epidemiology of Diabetes Interventions and Complications (EDIC) study. METHODS: Standard resting electrocardiogram (ECG) recordings were obtained annually in 997 participants (mean ± SD age 56.2 ± 6.8 years; T1D duration 34.7 ± 7.9 years; 48% female) between 2015 and 2022. The standard deviation of normally conducted R-R intervals (SDNN) and root mean square of successive differences between normal-to-normal R-R intervals (rMSSD) were used to define CAN using previously validated cut-offs in this cohort from gold-standard cardiovascular reflex tests (CARTs). Generalized estimating equation models were used to evaluate the association of ECG-derived CAN with individual risk factors over repeated time points. Kaplan-Meier estimates were used to describe the cumulative incidence of the first occurrence of any-CVD and of MACE by ECG-derived CAN status, and Cox proportional hazards regression models were used to estimate the effect of ECG-derived CAN adjusted for age and HbA1c. RESULTS: The prevalence of ECG-derived CAN (~ 64%) was stable. Higher pulse rate (OR [95% CI] 1.08 [1.07,1.10] per 1 bpm) and HbA1c (1.43 [1.29,1.58] per 1%) were the most significant risk factors for CAN, followed by older age, male sex, higher albumin excretion rate, and hypertension history. The cumulative incidence of first occurrence of any-CVD over 7 years of follow-up was significantly higher in participants with vs. without CAN (HR [95% CI] any-CVD 2.37 [1.43,3.94]), which remained significant adjusting for mean HbA1c and age, but was attenuated with further adjustment for other factors. CONCLUSIONS: The prevalence of and risk factors for standard resting ECG-derived CAN were similar to previously reported estimates from CARTs. CVD risk was significantly higher in those with vs. without CAN. These data support future studies examining the diagnostic utility of HRV indices at the point of care for risk stratification. TRIAL REGISTRATION: clinicaltrials.gov NCT00360815 and NCT00360893.

Overview

CoChat Summary

TL;DR

In 997 adults with type 1 diabetes in DCCT/EDIC, ECG-derived cardiovascular autonomic neuropathy (CAN) prevalence was stable at ~64% from 2015–2022. ECG-derived CAN was associated with higher risk of any-CVD and MACE over 7 years, though associations attenuated after adjustment for other risk factors.

Key findings

  • The average prevalence of ECG-derived CAN over the 7-year follow-up was 64% (62% intensive vs. 67% conventional, p = 0.0359), and median SDNN/rMSSD values and CAN prevalence were stable between EDIC years 22 and 29.
  • In the final multivariable GEE model, higher mean pulse rate (OR 1.08 [1.07, 1.10] per 1 bpm) and higher mean HbA1c (OR 1.43 [1.29, 1.58] per 1%) were the most significant risk factors for ECG-derived CAN, followed by older age (OR 1.21 per 5 years), male sex (OR 1.39), higher AER (OR 1.02 per 20% increase), and history of hypertension (OR 1.46).
  • Among participants free of CVD at EDIC year 22 (n = 873 for any-CVD; n = 947 for MACE), there were 88 incident any-CVD cases and 50 incident MACE cases over 7 years. Cumulative incidence was higher with vs. without ECG-derived CAN: unadjusted HR any-CVD 2.37 [1.43, 3.94] and MACE 3.33 [1.56, 7.10]; age- and HbA1c-adjusted HR any-CVD 1.71 [1.01, 2.90] and MACE 2.17 [1.00, 4.73].
  • In time-dependent Cox models, ECG-derived CAN was associated with any-CVD and MACE unadjusted (any-CVD 2.52 [1.46, 4.33]; MACE 3.33 [1.50, 7.41]) and after age/HbA1c adjustment (any-CVD 1.95 [1.12, 3.38]; MACE 2.32 [1.03, 5.25]), but was attenuated with further adjustment for other risk factors (any-CVD 1.69 [0.97, 2.95], p = 0.0663; MACE 2.21 [0.98, 5.00], p = 0.0568).

Methods

  • Longitudinal cohort study within DCCT/EDIC: 997 participants with type 1 diabetes and ECG-derived CAN data at EDIC year 22 (2015), followed through EDIC year 29 (2022); mean ± SD age 56.2 ± 6.8 years, type 1 diabetes duration 34.7 ± 7.9 years, 48% female.
  • Annual standard 10-second, 12-lead resting ECGs were centrally processed; SDNN and rMSSD were derived, and ECG-derived CAN was defined as SDNN < 17.13 and rMSSD < 24.94 ms based on prior validation against gold-standard cardiovascular autonomic reflex tests (CARTs).
  • Generalized estimating equation models evaluated risk factors over repeated time points; Kaplan-Meier estimates described cumulative incidence of first any-CVD and MACE; Cox proportional hazards models estimated the effect of ECG-derived CAN unadjusted and adjusted for age and HbA1c, including CAN as a time-dependent covariate in final multivariable models.

Limitations

  • Stated: the cohort was predominantly non-Hispanic White with type 1 diabetes, limiting generalizability to other type 1 diabetes populations; digital ECG data were not available before 2015.
  • Stated: analyses were exploratory and not adjusted for multiple testing.
  • Evident from the text: the observational design cannot establish causality, and the association between ECG-derived CAN and CVD/MACE attenuated after adjustment for other previously identified risk factors, leaving the independent effect uncertain.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12933-025-02856-9

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Median (interquartile range) SDNN and rMSSD values over time (A), Prevalence of ECG-derived CAN over time (B)
Fig. 1 Median (interquartile range) SDNN and rMSSD values over time (A), Prevalence of ECG-derived CAN over time (B)CC BY-NC-ND · PubMed Central
Fig. 2 Cumulative incidence of the first occurrence of any-CVD and of MACE by ECG-derived CAN status at EDIC year 22
Fig. 2 Cumulative incidence of the first occurrence of any-CVD and of MACE by ECG-derived CAN status at EDIC year 22CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

6 Valid · 0 Not valid · 0 Not checked · 24 Own results and interpretations

18 more claims

Create a free account to see all 30 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 3
  • It may state two separate claims as one. 4

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 34 references

Cited by

See all 5

Metadata

Authors
Braffett, B. H., El ghormli, L., Martin, C., White, N. H., Hirsch, I. B., Bantle, A., Carlson, A., Leschek, E., Gubitosi-Klug, R., Soliman, E. Z., Vella, A., Perkins, B. A., Bebu, I., Pop-Busui, R., & for the DCCT/EDIC Research Group
Affiliations
  • George Washington University (US)
  • University of Michigan (US)
  • Washington University in St. Louis (US)
  • University of Washington (US)
  • University of Minnesota (US)
  • HealthPartners (US)
  • National Institutes of Health (US)
  • Wake Forest University Health Sciences (US)
  • Mayo Clinic (US)
  • University of Toronto (CA)
Corresponding author
Braffett, Barbara H.
Venue
Cardiovascular Diabetology
Published
2025-08-13
Volume
24
Issue
1
Pages
334-334
ISSN
1475-2840 (ISSN-L)
OpenAlex
W4413116290
Cited by
5
References
34
Citations by year
2026: 4 · 2025: 1
FWCI
3.46
Type
journal article
Language
en
Open access
Licence
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK094176, U01 DK094157)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
cardiac autonomic neuropathy, heart rate variability, type 1 diabetes, cardiovascular disease, major adverse cardiovascular events, risk factors, pulse rate, HbA1c, urinary albumin excretion rate, hypertension, prevalence, cardiovascular reflex tests, cardiovascular risk stratification, diabetes complications
MeSH terms
Heart Disease Risk Factors, Adult, Aged, Autonomic Nervous System, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Electrocardiography, Female, Heart, Heart Rate, Humans, Longitudinal Studies, Male, Middle Aged, Prognosis, Time Factors, United States, Incidence, Prevalence, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes. https://app.cochat.ai/papers/10.1186/s12933-025-02856-9
The paper
Braffett, B. H., El ghormli, L., Martin, C., White, N. H., Hirsch, I. B., Bantle, A., Carlson, A., Leschek, E., Gubitosi-Klug, R., Soliman, E. Z., Vella, A., Perkins, B. A., Bebu, I., Pop-Busui, R., & for the DCCT/EDIC Research Group. (2025). Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-025-02856-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.